Tokyo, July 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062142) titled 'Evaluation of the current impact and utility of cancer genomic testing in Japan' on July 6.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Research Institute
Condition:
Condition - Solid cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - 1. To evaluate overall survival (OS) in patients who received molecularly targeted therapy (MBRT) recommended by the Expert Panel (EP) after comprehensive genomic profiling (CGP) testing, compared to patients who received standard of care (SOC) treatment.
2. To assess the post-CGP Cox proport...